Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of GDC-0980 (dual PI3K/mTOR inhibitor) in patients with advanced endometrial carcinoma: Final study results
    Meeting Abstract

    Makker, V.; Recio, F. O.; Ma, L.; Matutonis, U.; Lauchle, J. O.; Parmar, H.; Gilbert, H.; Wang, Y. L.; Koeppen, H.; Spoerke, J. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor-fusion protein, for treatment of recurrent/persistent endometrial cancer: GOG-0229N
    Meeting Abstract

    Makker, V.; Filiaci, V. L.; Chen, L. M.; Darus, C.; Kendrick, J. E.; Sutton, G.; Moxley, K.; Aghajanian, C.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II, single stage, cohort expansion study of MK-2206 in recurrent endometrial serous cancer
    Meeting Abstract

    Konstantinopoulos, P.; Makker, V.; Barry, W. T.; Liu, J.; Horowitz, N. S.; Birrer, M. J.; Doyle, L. A.; Berlin, S. T.; Whalen, C.; Van Hummelen, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265)
    Meeting Abstract

    Huh, W. K.; Brady, W. E.; Moore, K. N.; Lankes, H. A.; Monk, B. J.; Aghajanian, C.; Dizon, D. S.; Armstrong, D. K.; Thaker, P. H.; Fracasso, P. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of enzalutamide (Enza) on androgen receptor (AR) positive (+) ovarian cancer
    Meeting Abstract

    Grisham, R. N.; Thapi, D.; Berman, T.; de Stanchina, E.; Zhou, Q.; Iasonos, A.; Iyer, G.; Aghajanian, C.; Spriggs, D. R.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Correlation between Ca-125 and clinical disease progression in patients with ovarian cancer treated with bevacizumab: Analyses from 4 randomized trials
    Meeting Abstract

    Morales, L.; Burger, R. A.; Aghajanian, C.; Perren, T. J.; Pujade-Lauraine, E.; Moore, N.; Husain, A.
    International Journal of Gynecological Cancer (2014)

    Fulltext@MSK | Save
  • Randomized phase 2 evaluation of bevacizumab versus bevacizumab/fosbretabulin in recurrent ovarian, tubal or peritoneal carcinoma: A gynecologic oncology group study
    Meeting Abstract

    Monk, B.; Sill, M.; Walker, J.; DiSilvestro, P.; Sutton, G.; Tewari, K.; Pajon, E.; Martin, L.; Schilder, J.; Coleman, R.; more...
    International Journal of Gynecological Cancer (2014)

    Fulltext@MSK | Save
  • A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
    Journal Article

    Suidan, R. S.; Ramirez, P. T.; Sarasohn, D. M.; Teitcher, J. B.; Mironov, S.; Iyer, R. B.; Zhou, Q.; Iasonos, A.; Paul, H.; Hosaka, M.; more...
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations
    Meeting Abstract

    Shu, C. A.; Pike, M.; Jotwani, A. R.; Soslow, R. A.; Levine, D. A.; Konner, J.; Aghajanian, C.; Offit, K.; Barakat, R. R.; Kauff, N. D.
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial
    Meeting Abstract

    McMeekin, D. S.; Filiaci, V. L.; Aghajanian, C.; Cho, J.; Kim, J. W.; Disilvestro, P. A.; O'Malley, D.; Rutherford, T. J.; Van Le, L.; Randall, M. E.
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save